Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-08-09

Clinical Trial Update: Depakote ER in Borderline Personality Disorder [NA]

View source ↗

Summary

A completed clinical trial evaluated Depakote ER for Borderline Personality Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

Sponsor: University of Minnesota | Conditions: Borderline Personality Disorder | NA | Status: COMPLETED